Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urologica e Nefrologica 2007 September;59(3) > Minerva Urologica e Nefrologica 2007 September;59(3):367-77

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS  HOT TOPICS IN NEPHROLOGY IN 2007 

Minerva Urologica e Nefrologica 2007 September;59(3):367-77

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Immune monitoring after kidney transplantation

Gerrits J. H., Weimar W., Van Besouw N. M.

Department of Internal Medicine-Transplantation, Erasmus MC University Medical Center Rotterdam Rotterdam, The Netherlands


PDF


During the last decennium, research in the field of organ transplantation changed from studying mechanisms of acute rejection shortly after transplantation to understanding why patients benefit from their grafts only for a limited time, because of irreversible chronic rejection and serious side effects of immunosuppression. To avoid side effects, tapering or even withdrawal of immunosuppression in transplant recipients is warranted, provided this is not accompanied with graft loss. Noninvasive cell mediated immune tests could be helpful to identify transplant recipients in whom the immunosuppressive load can be safely reduced, and to identify patients at risk for chronic rejection. In the present report, we describe cellular assays to determine donor-specific responses in peripheral blood mononuclear cells from transplant recipients taken before transplantation and during tapering or withdrawal of immunosuppression.

top of page